Health · 3 views
Needle-free Strep A vaccine triggers local and bodywide immune responses in mice
New research by the Medicines and Healthcare products Regulatory Agency (MHRA) in partnership with the GSK Vaccines Institute for Global Health has moved a vaccine against the highly contagious group A streptococcus bacterium (Strep A) a…
AI Summary
Researchers from the Medicines and Healthcare products Regulatory Agency and the GSK Vaccines Institute for Global Health report that a new vaccine candidate against group A streptococcus (Strep A) has advanced in preclinical studies. The study, published in Human Vaccines & Immunotherapeutics in October 2026, demonstrates that the vaccine elicits both local and systemic immune responses in mice. The work also explores needle‑free delivery methods, suggesting the vaccine could be administered intranasally or sublingually.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Novel alpha radiopharmaceutical therapy shows promise in early-phase prostate cancer trialContinue reading
- Low-carb diet high in saturated fat shows mixed effects on cholesterol in two-year trialContinue reading
- Congress Mulls Ways to Fix the Surprise Billing LawContinue reading
- Fenebrutinib May Curb Chronic Active Lesions in Multiple SclerosisContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow